Emerald Health Therapeutics, Inc. EMHTF

Set alert

Price alert · EMHTF

All alert types
0.04 +0.04 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
0
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
—
High
—

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for EMHTF has not been loaded yet. Try again in a moment.

Valuation

P/E -0.3×
FY 2012: -0.7×FY 2013: -0.5×FY 2014: -0.7×FY 2015: -0.8×FY 2016: -1.1×FY 2017: -0.6×FY 2018: -0.3×FY 2019: -0.1×FY 2020: -0.3×FY 2021: -0.3×
FY 2012 5y median -0.3× FY 2021
P/S 1.2×
FY 2012: 0.4×FY 2013: 0.8×FY 2014: 0.0×FY 2015: 93.6×FY 2016: 13.2×FY 2017: 5.5×FY 2018: 4.6×FY 2019: 0.4×FY 2020: 1.0×FY 2021: 1.2×
FY 2012 5y median 1.2× FY 2021
P/B 0.3×
FY 2012: 0.2×FY 2013: 0.3×FY 2014: 1.0×FY 2015: -7.1×FY 2016: 0.9×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.2×FY 2021: 0.3×
FY 2012 5y median 0.1× FY 2021
P/FCF -0.6×
FY 2012: 4.1×FY 2013: -6.0×FY 2014: -1.3×FY 2015: -1.1×FY 2016: -1.5×FY 2017: -0.5×FY 2018: -0.2×FY 2019: -0.2×FY 2020: -0.8×FY 2021: -0.6×
FY 2012 5y median -0.5× FY 2021
EV/EBITDA 0.1×
FY 2012: 2.6×FY 2013: -10.5×FY 2014: -0.1×FY 2015: -0.8×FY 2016: -0.0×FY 2017: 4.7×FY 2018: 0.9×FY 2019: -0.3×FY 2020: 0.3×FY 2021: 0.1×
FY 2012 5y median 0.3× FY 2021
EV/Sales -0.4×
FY 2012: 0.7×FY 2013: 2.7×FY 2014: 0.0×FY 2015: 91.0×FY 2016: 0.5×FY 2017: -42.0×FY 2018: -12.7×FY 2019: 1.7×FY 2020: -0.9×FY 2021: -0.4×
FY 2012 5y median -0.9× FY 2021
FCF Yield -161.2%
FY 2012: 24.4%FY 2013: -16.6%FY 2014: -74.4%FY 2015: -88.4%FY 2016: -68.4%FY 2017: -196.8%FY 2018: -538.0%FY 2019: -553.5%FY 2020: -123.8%FY 2021: -161.2%
FY 2012 5y median -196.8% FY 2021

Profitability

Gross Margin -66.7%
FY 2012: 59.7%FY 2013: 54.8%FY 2014: 0.0%FY 2015: -552.9%FY 2016: -138.2%FY 2017: -30.5%FY 2018: -159.1%FY 2019: -71.2%FY 2020: -82.4%FY 2021: -66.7%
FY 2012 5y median -71.2% FY 2021
Operating Margin -397.4%
FY 2012: -3.4%FY 2013: -78.4%FY 2014: 0.0%FY 2015: -11175.7%FY 2016: -1145.2%FY 2017: -931.3%FY 2018: -1559.7%FY 2019: -552.4%FY 2020: -321.8%FY 2021: -397.4%
FY 2012 5y median -552.4% FY 2021
Net Margin -411.9%
FY 2012: -57.3%FY 2013: -167.0%FY 2014: 0.0%FY 2015: -11175.7%FY 2016: -1176.4%FY 2017: -931.3%FY 2018: -1590.5%FY 2019: -550.8%FY 2020: -370.9%FY 2021: -411.9%
FY 2012 5y median -550.8% FY 2021
ROE -118.5%
FY 2012: -26.9%FY 2013: -59.0%FY 2014: -138.7%FY 2015: 846.3%FY 2016: -80.5%FY 2017: -13.3%FY 2018: -18.2%FY 2019: -107.7%FY 2020: -59.3%FY 2021: -118.5%
FY 2012 5y median -59.3% FY 2021
ROIC -103.0%
FY 2012: -0.8%FY 2013: -13.5%FY 2014: -138.7%FY 2015: 846.3%FY 2016: -78.4%FY 2017: -12.7%FY 2018: -17.5%FY 2019: -85.7%FY 2020: -49.5%FY 2021: -103.0%
FY 2012 5y median -49.5% FY 2021
ROA -97.5%
FY 2012: -13.1%FY 2013: -26.0%FY 2014: -129.6%FY 2015: -453.2%FY 2016: -71.4%FY 2017: -11.8%FY 2018: -15.0%FY 2019: -71.5%FY 2020: -44.3%FY 2021: -97.5%
FY 2012 5y median -44.3% FY 2021

Growth (YoY)

Revenue -17.6%
FY 2012: 401.9%FY 2013: -49.7%FY 2014: -100.0%FY 2015: 0.0%FY 2016: 709.6%FY 2017: 270.1%FY 2018: 107.8%FY 2019: 943.1%FY 2020: -42.2%FY 2021: -17.6%
FY 2012 FY 2021
Operating Income -1.8%
FY 2012: 82.5%FY 2013: -1062.8%FY 2014: -2770.2%FY 2015: -32.2%FY 2016: 17.0%FY 2017: -201.0%FY 2018: -247.9%FY 2019: -269.4%FY 2020: 66.3%FY 2021: -1.8%
FY 2012 FY 2021
EPS (diluted) 8.7%
FY 2012: -129.6%FY 2013: -46.6%FY 2014: 27.2%FY 2015: -6.5%FY 2016: 27.7%FY 2017: -79.8%FY 2018: -122.9%FY 2019: -245.5%FY 2020: 69.7%FY 2021: 8.7%
FY 2012 FY 2021
Free Cash Flow -29.0%
FY 2012: 103.2%FY 2013: -169.5%FY 2014: -9337.4%FY 2015: -75.7%FY 2016: 11.5%FY 2017: -339.4%FY 2018: -374.3%FY 2019: -2.3%FY 2020: 71.3%FY 2021: -29.0%
FY 2012 FY 2021

Financial Health

Current Ratio 3.1×
FY 2012: 18.3×FY 2013: 3.4×FY 2014: 13.7×FY 2015: 0.3×FY 2016: 7.6×FY 2017: 8.2×FY 2018: 1.8×FY 2019: 0.6×FY 2020: 2.4×FY 2021: 3.1×
FY 2012 5y median 2.4× FY 2021
Quick Ratio 3.0×
FY 2012: 18.3×FY 2013: 3.4×FY 2014: 13.7×FY 2015: 0.1×FY 2016: 6.9×FY 2017: 8.1×FY 2018: 1.5×FY 2019: 0.2×FY 2020: 2.2×FY 2021: 3.0×
FY 2012 5y median 2.2× FY 2021
Debt / Equity 0.1×
FY 2012: 1.0×FY 2013: 1.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.1×FY 2021: 0.1×
FY 2012 5y median 0.1× FY 2021
Net Debt / EBITDA 0.4×
FY 2012: 1.2×FY 2013: -7.5×FY 2014: 0.7×FY 2015: 0.0×FY 2016: 1.2×FY 2017: 5.3×FY 2018: 1.2×FY 2019: -0.2×FY 2020: 0.7×FY 2021: 0.4×
FY 2012 5y median 0.7× FY 2021
Interest Coverage -55.0×
FY 2012: -0.1×FY 2013: -1.8×FY 2014: 0.0×FY 2015: 0.0×FY 2016: -73.1×FY 2017: 0.0×FY 2018: -139×FY 2019: -147×FY 2020: -7.6×FY 2021: -55.0×
FY 2012 5y median -55.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31